Bausch + Lumb, VIS100 Injector System
Folders And Injectors, Intraocular Lens (Iol). 510(k) K133146, from Bausch & Lomb (Irvine, CA). Product code MSS, class 1.
As of Nov 18, 2026, K133146 is an FDA 510(k) held by Bausch & Lomb, substantially equivalent on Jan 3, 2014 after 78 days, with no recalls tied to it in FDA's recall database.
- Review time: 78 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Bausch + Lomb VIS100 Injector System is indicated for folding and injection of Bausch + Lomb intraocular lenses approved for use with this injector. The indications for use are identical to the indications for use of the predicate device. *1* *K133146 Pg. 2 of 3*
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Bausch & Lomb Iol InjectorK113852 · Bausch & Lomb, Inc. · Sep 28, 2012
Other MSS clearances
The newest 510(k)s for the same product code; their median review was 54 days; see every MSS device- RxSight® Insertion DeviceK261174 · Rxsight, Inc. · Jun 10, 2026
- ACCUJECT Injector Set 2.1-1P (LP604590)K252540 · Medicel AG · Sep 16, 2025
- EyeGility™ Inserter for Preloaded enVista IOLsK242389 · Bausch & Lomb, Incorporated · Oct 10, 2024
- Accuject Refra Injector AR2900K231106 · Medicel AG · Sep 19, 2023
- RxSight® Insertion Device (63002)K231838 · Rxsight, Inc. · Aug 15, 2023
- RxSight Insertion DeviceK231466 · Rxsight, Inc. · Jun 12, 2023
- CLAREON MONARCH IV IOL Delivery SystemK212039 · Alcon Laboratories, Inc. · Aug 23, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Oct 17, 2013
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.4300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files